Leiomyoma: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Leiomyoma}}
{{Leiomyoma}}
'''For patient information, click [[Uterine fibroids (patient information)|here]]'''


{{CMG}}; {{AE}} {{CZ}} {{SC}}
{{CMG}}; {{AE}} {{CZ}} {{SC}}


{{SK}}
{{SK}}
 
==Overview==
==[[Leiomyoma overview|Overview]]==
 
==[[Leiomyoma historical perspective|Historical Perspective]]==
 
==[[Leiomyoma classification|Classification]]==
 
==[[Leiomyoma pathophysiology|Pathophysiology]]==
 
==[[Leiomyoma differential diagnosis|Differentiating Leiomyoma from other Diseases]]==
 
==[[Leiomyoma epidemiology and demographics|Epidemiology and Demographics]]==
 
==[[Leiomyoma risk factors|Risk Factors]]==
 
==[[Leiomyoma screening|Screening]]==
 
==[[Leiomyoma natural history|Natural History, Complications and Prognosis]]==
 
==Diagnosis==
[[Leiomyoma staging|Staging]] | [[Leiomyoma history and symptoms|History and Symptoms]] | [[Leiomyoma physical examination|Physical Examination]] | [[Leiomyoma laboratory findings|Laboratory Findings]] | [[Leiomyoma X ray|X Ray]] | [[Leiomyoma CT|CT]] | [[Leiomyoma MRI|MRI]] | [[Leiomyoma ultrasound|Ultrasound]] | [[Leiomyoma other imaging findings|Other Imaging Findings]] | [[Leiomyoma other diagnostic studies|Other Diagnostic Studies]] | [[Leiomyoma biopsy|Biopsy]]
 
==Treatment==
[[Leiomyoma medical therapy|Medical Therapy]] | [[Leiomyoma surgery|Surgery]] | [[Leiomyoma primary prevention|Primary Prevention]] | [[Leiomyoma secondary prevention|Secondary Prevention]] | [[Leiomyoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Leiomyoma future or investigational therapies|Future or Investigational Therapies]]
 
==Related Chapters==
* [[Myosarcoma]]
 


==Pathophysiology==
==Pathophysiology==
Line 126: Line 97:


</gallery>
</gallery>


==ultrasound==
==ultrasound==

Revision as of 15:47, 9 December 2015

Template:Leiomyoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2] Shanshan Cen, M.D. [3]

Synonyms and keywords:

Overview

Pathophysiology

Uterine Leiomyomata

Uterine fibroids are leiomyomata of the uterine smooth muscle. As other leiomyomata, they are benign, but may lead to excessive menstrual bleeding (menorrhagia), often cause anemia and may lead to infertility. Enucleation is removal of fibroids without removing the uterus (hysterectomy), which is also commonly performed. Laser surgery (called myolysis) is increasingly used, and provides a viable alternative to surgery.

Uterine leiomyomas originate in the myometrium and are classified by location:

Estrogen and progesterone usually stimulate their growth, and hormone suppression may hence decrease their size.

Esophageal

They are also the most common benign esophageal tumour, though this accounts for less than 1% of esophageal neoplasms. The remainder consists mainly of carcinomas. Although the vast majority of benign esophageal tumors are clinically silent and go undetected, large or strategically located tumors may become symptomatic. [1]

Leiomyoma of Jejunum

Leiomyoma is the most common benign tumor of small bowel. Approximately 50% of cases are found in the jejunum, followed by the ileum in 31% of cases. Almost one half of all lesions are less than 5 centimeters. [2]

Gross Pathology


epidemiology and demographics

The disease is 5 times more common in Afro-American females.

CT

CT images demonstrate a right broad ligament leiomyoma

MRI

  • Differential diagnosis at MR imaging includes adenomyosis, solid adnexal mass, focal myometrial contraction, and uterine leiomyosarcoma.
  • Nondegenerated uterine leiomyomas have a typical appearance at MR imaging: well-circumscribed masses of homogeneously decreased signal intensity compared with that of the outer myometrium on T2-weighted images.
  • Degenerated leiomyomas have variable appearances on T2-weighted images and contrast-enhanced images.

Patient #1: MR images demonstrate large degenerating leiomyomas

Patient #2: MR images demonstrate a leiomyoma prolapsing into the endometrial canal

ultrasound

Diagnosis depends on position of the myomas. Traditional transabdominal or transvaginal ultrasonogram can detect large submucosal and transmural myomas. For submucosal myomas saline infusion sonography is the best.

Other Imaging Findings

Hysterosalpingogram(HSG)

Hysterosalpingogram(HSG) reveals a submucosal leiomyoma

medical therapy

GnRH analogues for 3-6 months are used to reduce the size of the myomas. It usually reduce the size by 60% to 70%. But once the medication is stopped the myomas will grow back.

surgery

Myomectomy is a choice to remove myomas. It is usually done when the client wants to preserve their fertility. Total Abdominal or Vaginal hysterectomy with Bilateral Salpingo-oophorectomy is the definitive treatment.


Template:WikiDoc Sources

  1. James C. Chou, MD & Frank G. Gress, MD. "Benign Esophageal Tumors". Esophageal Cancer Overview (Cancer of the Esophagus). Retrieved 2007-03-21. Unknown parameter |publsiher= ignored (|publisher= suggested) (help)
  2. By Michael P. Buetow, M.D. "Leiomyoma of Jejunum". Retrieved 2007-03-21. Unknown parameter |publsiher= ignored (|publisher= suggested) (help)